New York (GenomeWeb) – The US Food and Drug Administration has granted Emergency Use Authorization to a Zika test from Roche that runs on the firm's LightCycler 480 Instrument II or Cobas z 480 Analyzer.

The LightMix Zika real-time RT-PCR Test is an easy-to-use molecular diagnostic test that enables healthcare professionals to quickly detect viral RNA in plasma or serum of patients meeting US Centers for Disease Control and Prevention clinical or epidemiological criteria, Roche said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.